Skip to main content
Top
Published in: Journal of Nephrology 2/2019

01-04-2019 | Original Article

Transient and persistent acute kidney injury in acute liver failure

Authors: Silvia Coelho, José Nuno Fonseca, Joana Gameiro, Sofia Jorge, José Velosa, José António Lopes

Published in: Journal of Nephrology | Issue 2/2019

Login to get access

Abstract

Background

Acute Kidney Injury (AKI) is a very frequent complication in the Acute Liver Failure (ALF) population associated with negative outcomes. We aim to evaluate the impact of AKI duration on the outcomes of an ALF population.

Methods

A 20-year retrospective analysis of ALF patients admitted to an Intensive Care Unit (ICU) was performed. Chronic liver failure, chronic kidney disease on renal replacement therapy, dialysis requirement within the week prior or an ICU stay of less than 48 h after AKI diagnosis, were exclusion criteria. AKI was defined according to the KDIGO criteria and classified into transient (< 48 h duration) or persistent (48 h duration).

Results

A total of 51 patients were included in the analysis and most had AKI (66.7%). Persistent AKI patients (70.6%) presented more frequently with AKI at admission and a higher SOFA score than transient AKI and no AKI, p < 0.05. More severe AKI, sepsis, vasopressor support and mechanical ventilation were also more common (p < 0.05). Nineteen (55.9%) were classified as persistent AKI exclusively by serum creatinine and 15 (44.1%) by both serum creatinine and urine output criteria. Mean survival time at 30 days was 11.3 days for persistent AKI, 25.3 days for transient AKI and 27.0 days for no AKI, p = 0.01. Adjusted multivariate cox regression analysis showed that persistent AKI predicted in-hospital mortality but it lost significance when AKI severity was introduced in the model.

Conclusion

Persistent AKI was common in ALF patients and associated with more severe AKI, worst systemic complications and a higher 30-day mortality, compared to transient and no AKI patients.
Literature
1.
go back to reference Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group (2012) KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl 2:1–138CrossRef Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group (2012) KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl 2:1–138CrossRef
2.
go back to reference Chawla LS, Bellomo R, Bihorac A et al (2017) Acute kidney disease and renal recovery: consensus report of the Acute Disease Quality Initiative (ADQI) 16 Workgroup. Nat Rev Nephrol Nat Res 13(4):241–257CrossRef Chawla LS, Bellomo R, Bihorac A et al (2017) Acute kidney disease and renal recovery: consensus report of the Acute Disease Quality Initiative (ADQI) 16 Workgroup. Nat Rev Nephrol Nat Res 13(4):241–257CrossRef
3.
go back to reference Tujios SR, Hynan LS, Vazquez MA et al (2015) Risk factors and outcomes of acute kidney injury in patients with acute liver failure. Clin Gastroenterol Hepatol 13:352–359CrossRefPubMed Tujios SR, Hynan LS, Vazquez MA et al (2015) Risk factors and outcomes of acute kidney injury in patients with acute liver failure. Clin Gastroenterol Hepatol 13:352–359CrossRefPubMed
4.
go back to reference O’Riordan A, Brummell Z, Sizer E et al (2011) Acute kidney injury in patients admitted to a liver intensive therapy unit with paracetamol-induced hepatotoxicity. Nephrol Dial Transpl 26:3501–3508CrossRef O’Riordan A, Brummell Z, Sizer E et al (2011) Acute kidney injury in patients admitted to a liver intensive therapy unit with paracetamol-induced hepatotoxicity. Nephrol Dial Transpl 26:3501–3508CrossRef
5.
go back to reference Hoofnagle JH, Carithers RL, Shapiro C, Ascher N (1995) Fulminant hepatic failure: summary of a workshop. Hepatology 21(1):240–252PubMed Hoofnagle JH, Carithers RL, Shapiro C, Ascher N (1995) Fulminant hepatic failure: summary of a workshop. Hepatology 21(1):240–252PubMed
7.
go back to reference Leithead JA, Ferguson JW, Bates CM et al (2009) The systemic inflammatory response syndrome is predictive of renal dysfunction in patients with non-paracetamol-induced acute liver failure. Gut 58:443–449CrossRefPubMed Leithead JA, Ferguson JW, Bates CM et al (2009) The systemic inflammatory response syndrome is predictive of renal dysfunction in patients with non-paracetamol-induced acute liver failure. Gut 58:443–449CrossRefPubMed
8.
go back to reference Bellomo R, Ronco C, Kellum JA et al (2004) Acute renal failure—definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 8(4):R204–R212CrossRefPubMedPubMedCentral Bellomo R, Ronco C, Kellum JA et al (2004) Acute renal failure—definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 8(4):R204–R212CrossRefPubMedPubMedCentral
9.
go back to reference Singer M, Deutschman CS, Seymour CW et al (2016) The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 315:801–810CrossRefPubMedPubMedCentral Singer M, Deutschman CS, Seymour CW et al (2016) The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 315:801–810CrossRefPubMedPubMedCentral
10.
go back to reference Vincent JL, Moreno R, Takala J et al (1996) The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 22(7):707–710CrossRefPubMed Vincent JL, Moreno R, Takala J et al (1996) The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 22(7):707–710CrossRefPubMed
11.
go back to reference Case J, Khan S, Khalid R, Khan A (2013) Epidemiology of acute kidney injury in the intensive care unit. Crit Care Res Pract 2013:479730–479739PubMedPubMedCentral Case J, Khan S, Khalid R, Khan A (2013) Epidemiology of acute kidney injury in the intensive care unit. Crit Care Res Pract 2013:479730–479739PubMedPubMedCentral
12.
go back to reference Koeze J, Keus F, Dieperink W et al (2017) Incidence, timing and outcome of AKI in critically ill patients varies with the definition used and the addition of urine output criteria. BMC Nephrol 18:70CrossRefPubMedPubMedCentral Koeze J, Keus F, Dieperink W et al (2017) Incidence, timing and outcome of AKI in critically ill patients varies with the definition used and the addition of urine output criteria. BMC Nephrol 18:70CrossRefPubMedPubMedCentral
13.
go back to reference Lopes JA, Melo MJ, Costa AC et al (2012) Acute kidney injury and in-hospital mortality in critically ill patients with cirrhosis: a cohort study. Gut 61:955–956CrossRefPubMed Lopes JA, Melo MJ, Costa AC et al (2012) Acute kidney injury and in-hospital mortality in critically ill patients with cirrhosis: a cohort study. Gut 61:955–956CrossRefPubMed
14.
go back to reference Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group (2013) KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl 3:1–150CrossRef Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group (2013) KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl 3:1–150CrossRef
15.
go back to reference Jin K, Murugan R, Sileanu FE et al (2017) Intensive monitoring of urine output is associated with increased detection of acute kidney injury and improved outcomes. Chest 152:972–979CrossRefPubMed Jin K, Murugan R, Sileanu FE et al (2017) Intensive monitoring of urine output is associated with increased detection of acute kidney injury and improved outcomes. Chest 152:972–979CrossRefPubMed
16.
go back to reference Teixeira C, Garzotto F, Piccinni P et al (2013) Fluid balance and urine volume are independent predictors of mortality in acute kidney injury. Crit Care 17:R14CrossRefPubMedPubMedCentral Teixeira C, Garzotto F, Piccinni P et al (2013) Fluid balance and urine volume are independent predictors of mortality in acute kidney injury. Crit Care 17:R14CrossRefPubMedPubMedCentral
17.
go back to reference Uchino S, Bellomo R, Morimatsu H et al (2009) Discontinuation of continuous renal replacement therapy: a post hoc analysis of a prospective multicenter observational study. Crit Care Med 37:2576–2582CrossRefPubMed Uchino S, Bellomo R, Morimatsu H et al (2009) Discontinuation of continuous renal replacement therapy: a post hoc analysis of a prospective multicenter observational study. Crit Care Med 37:2576–2582CrossRefPubMed
18.
go back to reference Maiwall R, Kumar G, Bharadwaj A et al (2017) AKI persistence at 48 h predicts mortality in patients with acute on chronic liver failure. Hepatol Int 11:529–539CrossRefPubMed Maiwall R, Kumar G, Bharadwaj A et al (2017) AKI persistence at 48 h predicts mortality in patients with acute on chronic liver failure. Hepatol Int 11:529–539CrossRefPubMed
19.
go back to reference Sood MM, Shafer LA, Ho J et al (2014) Early reversible acute kidney injury is associated with improved survival in septic shock. J Crit Care 29:711–717CrossRefPubMed Sood MM, Shafer LA, Ho J et al (2014) Early reversible acute kidney injury is associated with improved survival in septic shock. J Crit Care 29:711–717CrossRefPubMed
20.
go back to reference Coca SG, King JT, Rosenthal RA et al (2010) The duration of postoperative acute kidney injury is an additional parameter predicting long-term survival in diabetic veterans. Kidney Int 78:926–933CrossRefPubMedPubMedCentral Coca SG, King JT, Rosenthal RA et al (2010) The duration of postoperative acute kidney injury is an additional parameter predicting long-term survival in diabetic veterans. Kidney Int 78:926–933CrossRefPubMedPubMedCentral
22.
go back to reference Perinel S, Vincent F, Lautrette A et al (2015) Transient and persistent acute kidney injury and the risk of hospital mortality in critically ill patients: results of a Multicenter Cohort Study. Crit Care Med 43:e269–e275CrossRefPubMed Perinel S, Vincent F, Lautrette A et al (2015) Transient and persistent acute kidney injury and the risk of hospital mortality in critically ill patients: results of a Multicenter Cohort Study. Crit Care Med 43:e269–e275CrossRefPubMed
23.
go back to reference Brown JR, Kramer RS, Coca SG, Parikh CR (2010) Duration of acute kidney injury impacts long-term survival after cardiac surgery. Ann Thorac Surg 90:1142–1148CrossRefPubMed Brown JR, Kramer RS, Coca SG, Parikh CR (2010) Duration of acute kidney injury impacts long-term survival after cardiac surgery. Ann Thorac Surg 90:1142–1148CrossRefPubMed
Metadata
Title
Transient and persistent acute kidney injury in acute liver failure
Authors
Silvia Coelho
José Nuno Fonseca
Joana Gameiro
Sofia Jorge
José Velosa
José António Lopes
Publication date
01-04-2019
Publisher
Springer International Publishing
Published in
Journal of Nephrology / Issue 2/2019
Print ISSN: 1121-8428
Electronic ISSN: 1724-6059
DOI
https://doi.org/10.1007/s40620-018-00568-w

Other articles of this Issue 2/2019

Journal of Nephrology 2/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine